Molecular Partners' Net Loss Declines in H1

01:24 AM EDT, 08/25/2026 (MT Newswires) -- Molecular Partners (MOLN.SW) said Tuesday its net loss narrowed in the first half. Net loss attributable to shareholders for the six months ended June 30 was 26.7 million francs, compared with 37.2 million francs earlier. Loss per share moved to 0.70 franc from 1 franc. The clinical-stage biotech company did not report revenue for the six-month period.